Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Vector Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Vector Vaccinesmarket, defines the market attractiveness level of Recombinant Vector Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Vector Vaccines industry, describes the types of Recombinant Vector Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Vector Vaccines market and the development prospects and opportunities of Recombinant Vector Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Vector Vaccines market in Chapter 13.
By Player:
CNBG
Changsheng Life
ChengDa Bio
SANOFI PASTEUR SA
Hualan Bio
NuoCheng Bio
SINOVAC BIOTECH
Novartis
Kangtai
Zhifei
GSK
By Type:
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others
By End-User:
For Adult
For Child
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Vector Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Vector Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Vector Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Vector Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Vector Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Vector Vaccines Consumption (2017-2022)
-
7.2 United States Recombinant Vector Vaccines Consumption (2017-2022)
-
7.3 Europe Recombinant Vector Vaccines Consumption (2017-2022)
-
7.4 China Recombinant Vector Vaccines Consumption (2017-2022)
-
7.5 Japan Recombinant Vector Vaccines Consumption (2017-2022)
-
7.6 India Recombinant Vector Vaccines Consumption (2017-2022)
-
7.7 South Korea Recombinant Vector Vaccines Consumption (2017-2022)
8 Region and Country-wise Recombinant Vector Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Vector Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Vector Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Vector Vaccines Consumption Forecast (2022-2028)
-
8.4 China Recombinant Vector Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Vector Vaccines Consumption Forecast (2022-2028)
-
8.6 India Recombinant Vector Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Vector Vaccines Consumption Forecast (2022-2028)
9 Global Recombinant Vector Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Vector Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Varicella Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Influenza Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Polio Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hepatitis A Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Rabies Consumption and Growth Rate (2017-2022)
-
9.1.6 Global BCG Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Pertussis, Diphtheria, tetanus Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Pneumococcal Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Vector Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global For Adult Consumption and Growth Rate (2017-2022)
-
9.2.2 Global For Child Consumption and Growth Rate (2017-2022)
10 Global Recombinant Vector Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Vector Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Varicella Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Polio Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Rabies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global BCG Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Pertussis, Diphtheria, tetanus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Vector Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global For Adult Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global For Child Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Vector Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Vector Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Vector Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Vector Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Vector Vaccines Market Competitive Analysis
-
14.1 CNBG
-
14.1.1 CNBG Company Details
-
14.1.2 CNBG Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CNBG Recombinant Vector Vaccines Product and Service
-
14.2 Changsheng Life
-
14.2.1 Changsheng Life Company Details
-
14.2.2 Changsheng Life Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Changsheng Life Recombinant Vector Vaccines Product and Service
-
14.3 ChengDa Bio
-
14.3.1 ChengDa Bio Company Details
-
14.3.2 ChengDa Bio Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 ChengDa Bio Recombinant Vector Vaccines Product and Service
-
14.4 SANOFI PASTEUR SA
-
14.4.1 SANOFI PASTEUR SA Company Details
-
14.4.2 SANOFI PASTEUR SA Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 SANOFI PASTEUR SA Recombinant Vector Vaccines Product and Service
-
14.5 Hualan Bio
-
14.5.1 Hualan Bio Company Details
-
14.5.2 Hualan Bio Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Hualan Bio Recombinant Vector Vaccines Product and Service
-
14.6 NuoCheng Bio
-
14.6.1 NuoCheng Bio Company Details
-
14.6.2 NuoCheng Bio Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 NuoCheng Bio Recombinant Vector Vaccines Product and Service
-
14.7 SINOVAC BIOTECH
-
14.7.1 SINOVAC BIOTECH Company Details
-
14.7.2 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 SINOVAC BIOTECH Recombinant Vector Vaccines Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Recombinant Vector Vaccines Product and Service
-
14.9 Kangtai
-
14.9.1 Kangtai Company Details
-
14.9.2 Kangtai Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Kangtai Recombinant Vector Vaccines Product and Service
-
14.10 Zhifei
-
14.10.1 Zhifei Company Details
-
14.10.2 Zhifei Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Zhifei Recombinant Vector Vaccines Product and Service
-
14.11 GSK
-
14.11.1 GSK Company Details
-
14.11.2 GSK Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 GSK Recombinant Vector Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Vector Vaccines
-
Figure Recombinant Vector Vaccines Picture
-
Table Global Recombinant Vector Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Vector Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Vector Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Vector Vaccines Consumption by Country (2017-2022)
-
Figure United States Recombinant Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Vector Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Vector Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Vector Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Varicella Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Consumption and Growth Rate (2017-2022)
-
Figure Global Polio Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis A Consumption and Growth Rate (2017-2022)
-
Figure Global Rabies Consumption and Growth Rate (2017-2022)
-
Figure Global BCG Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
Figure Global Pertussis, Diphtheria, tetanus Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global For Adult Consumption and Growth Rate (2017-2022)
-
Figure Global For Child Consumption and Growth Rate (2017-2022)
-
Figure Global Varicella Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polio Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rabies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BCG Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pertussis, Diphtheria, tetanus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumococcal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For Child Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Vector Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Vector Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table CNBG (Foundation Year, Company Profile and etc.)
-
Table CNBG Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CNBG Recombinant Vector Vaccines Product and Service
-
Table Changsheng Life (Foundation Year, Company Profile and etc.)
-
Table Changsheng Life Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changsheng Life Recombinant Vector Vaccines Product and Service
-
Table ChengDa Bio (Foundation Year, Company Profile and etc.)
-
Table ChengDa Bio Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table ChengDa Bio Recombinant Vector Vaccines Product and Service
-
Table SANOFI PASTEUR SA (Foundation Year, Company Profile and etc.)
-
Table SANOFI PASTEUR SA Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table SANOFI PASTEUR SA Recombinant Vector Vaccines Product and Service
-
Table Hualan Bio (Foundation Year, Company Profile and etc.)
-
Table Hualan Bio Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Bio Recombinant Vector Vaccines Product and Service
-
Table NuoCheng Bio (Foundation Year, Company Profile and etc.)
-
Table NuoCheng Bio Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table NuoCheng Bio Recombinant Vector Vaccines Product and Service
-
Table SINOVAC BIOTECH (Foundation Year, Company Profile and etc.)
-
Table SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table SINOVAC BIOTECH Recombinant Vector Vaccines Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Recombinant Vector Vaccines Product and Service
-
Table Kangtai (Foundation Year, Company Profile and etc.)
-
Table Kangtai Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kangtai Recombinant Vector Vaccines Product and Service
-
Table Zhifei (Foundation Year, Company Profile and etc.)
-
Table Zhifei Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhifei Recombinant Vector Vaccines Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Recombinant Vector Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Recombinant Vector Vaccines Product and Service
-
